100 related articles for article (PubMed ID: 7875491)
1. HLA-DR and HLA-DQ are not markers for rapid disease progression in primary sclerosing cholangitis.
Olerup O; Olsson R; Hultcrantz R; Broome U
Gastroenterology; 1995 Mar; 108(3):870-8. PubMed ID: 7875491
[TBL] [Abstract][Full Text] [Related]
2. HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.
Spurkland A; Saarinen S; Boberg KM; Mitchell S; Broome U; Caballeria L; Ciusani E; Chapman R; Ercilla G; Fausa O; Knutsen I; Pares A; Rosina F; Olerup O; Thorsby E; Schrumpf E
Tissue Antigens; 1999 May; 53(5):459-69. PubMed ID: 10372541
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis.
Donaldson PT; Norris S
Autoimmunity; 2002 Dec; 35(8):555-64. PubMed ID: 12765483
[TBL] [Abstract][Full Text] [Related]
4. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
[TBL] [Abstract][Full Text] [Related]
5. Does HLA status influence prognosis in primary sclerosing cholangitis?
Chapman R
Gastroenterology; 1995 Mar; 108(3):937-40. PubMed ID: 7875501
[No Abstract] [Full Text] [Related]
6. Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes.
Wiencke K; Karlsen TH; Boberg KM; Thorsby E; Schrumpf E; Lie BA; Spurkland A
Tissue Antigens; 2007 Feb; 69(2):161-9. PubMed ID: 17257319
[TBL] [Abstract][Full Text] [Related]
7. Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles.
Wiencke K; Spurkland A; Schrumpf E; Boberg KM
Hepatology; 2001 Oct; 34(4 Pt 1):625-30. PubMed ID: 11584356
[TBL] [Abstract][Full Text] [Related]
8. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen-C genes and susceptibility to primary sclerosing cholangitis.
Moloney MM; Thomson LJ; Strettell MJ; Williams R; Donaldson PT
Hepatology; 1998 Sep; 28(3):660-2. PubMed ID: 9731555
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.
Laivoranta-Nyman S; Möttönen T; Hermann R; Tuokko J; Luukkainen R; Hakala M; Hannonen P; Korpela M; Yli-Kerttula U; Toivanen A; Ilonen J;
Ann Rheum Dis; 2004 Nov; 63(11):1406-12. PubMed ID: 15479890
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility alleles and haplotypes of human leukocyte antigen DRB1, DQA1, and DQB1 in autoimmune polyglandular syndrome type III in Japanese population.
Hashimoto K; Maruyama H; Nishiyama M; Asaba K; Ikeda Y; Takao T; Iwasaki Y; Kumon Y; Suehiro T; Tanimoto N; Mizobuchi M; Nakamura T
Horm Res; 2005; 64(5):253-60. PubMed ID: 16254435
[TBL] [Abstract][Full Text] [Related]
12. Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis.
Farrant JM; Doherty DG; Donaldson PT; Vaughan RW; Hayllar KM; Welsh KI; Eddleston AL; Williams R
Hepatology; 1992 Aug; 16(2):390-5. PubMed ID: 1639348
[TBL] [Abstract][Full Text] [Related]
13. The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
Boberg KM; Spurkland A; Rocca G; Egeland T; Saarinen S; Mitchell S; Broomé U; Chapman R; Olerup O; Pares A; Rosina F; Schrumpf E
Scand J Gastroenterol; 2001 Aug; 36(8):886-90. PubMed ID: 11495087
[TBL] [Abstract][Full Text] [Related]
14. Association of tumor necrosis factor polymorphism with primary sclerosing cholangitis.
Bernal W; Moloney M; Underhill J; Donaldson PT
J Hepatol; 1999 Feb; 30(2):237-41. PubMed ID: 10068102
[TBL] [Abstract][Full Text] [Related]
15. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis.
Karlsen TH; Boberg KM; Vatn M; Bergquist A; Hampe J; Schrumpf E; Thorsby E; Schreiber S; Lie BA;
Genes Immun; 2007 Apr; 8(3):275-8. PubMed ID: 17301827
[TBL] [Abstract][Full Text] [Related]
16. [HLA-DRB1/DQA1/DQB1 alleles and haplotypes in Czech children with celiac sprue].
Kotalová R; Vraná M; Dobrovolná M; Nevoral J; Loudová M
Cas Lek Cesk; 2002 Aug; 141(16):518-22. PubMed ID: 12404952
[TBL] [Abstract][Full Text] [Related]
17. The association between HLA DR, DQ antigens, and vulval lichen sclerosus in the UK: HLA DRB112 and its associated DRB112/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus.
Gao XH; Barnardo MC; Winsey S; Ahmad T; Cook J; Agudelo JD; Zhai N; Powell JJ; Fuggle SV; Wojnarowska F
J Invest Dermatol; 2005 Nov; 125(5):895-9. PubMed ID: 16297186
[TBL] [Abstract][Full Text] [Related]
18. HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis.
Zetterquist H; Broomé U; Einarsson K; Olerup O
Gut; 1992 Jul; 33(7):942-6. PubMed ID: 1644334
[TBL] [Abstract][Full Text] [Related]
19. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
[TBL] [Abstract][Full Text] [Related]
20. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
